1. Home
  2. OPTN vs MHH Comparison

OPTN vs MHH Comparison

Compare OPTN & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • MHH
  • Stock Information
  • Founded
  • OPTN 2010
  • MHH 1986
  • Country
  • OPTN United States
  • MHH United States
  • Employees
  • OPTN N/A
  • MHH N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • MHH Professional Services
  • Sector
  • OPTN Health Care
  • MHH Consumer Discretionary
  • Exchange
  • OPTN Nasdaq
  • MHH Nasdaq
  • Market Cap
  • OPTN 117.6M
  • MHH 112.7M
  • IPO Year
  • OPTN 2017
  • MHH N/A
  • Fundamental
  • Price
  • OPTN $0.71
  • MHH $9.35
  • Analyst Decision
  • OPTN Strong Buy
  • MHH
  • Analyst Count
  • OPTN 2
  • MHH 0
  • Target Price
  • OPTN $4.00
  • MHH N/A
  • AVG Volume (30 Days)
  • OPTN 516.5K
  • MHH 8.7K
  • Earning Date
  • OPTN 11-07-2024
  • MHH 10-30-2024
  • Dividend Yield
  • OPTN N/A
  • MHH N/A
  • EPS Growth
  • OPTN N/A
  • MHH N/A
  • EPS
  • OPTN N/A
  • MHH N/A
  • Revenue
  • OPTN $75,058,000.00
  • MHH $190,188,000.00
  • Revenue This Year
  • OPTN $24.44
  • MHH N/A
  • Revenue Next Year
  • OPTN $49.00
  • MHH $3.85
  • P/E Ratio
  • OPTN N/A
  • MHH N/A
  • Revenue Growth
  • OPTN 3.91
  • MHH N/A
  • 52 Week Low
  • OPTN $0.65
  • MHH $7.15
  • 52 Week High
  • OPTN $2.10
  • MHH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 33.40
  • MHH 43.55
  • Support Level
  • OPTN $0.65
  • MHH $9.09
  • Resistance Level
  • OPTN $0.70
  • MHH $10.52
  • Average True Range (ATR)
  • OPTN 0.05
  • MHH 0.52
  • MACD
  • OPTN -0.00
  • MHH -0.09
  • Stochastic Oscillator
  • OPTN 24.67
  • MHH 16.52

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

About MHH Mastech Digital Inc

Mastech Digital Inc is a provider of Digital Transformation IT Services. The Company offers data & analytics solutions & IT staffing services for both digital & mainstream technologies. The Group has two segments. Its Data & Analytics Services segment delivers specialized data management, data engineering, customer experience consulting, data analytics & cloud services to customers globally. IT Staffing Services segment combines technical expertise with business process experience to deliver a broad range of services in digital & mainstream technologies. The company derives a majority of its revenue from IT staffing services. Geographically, the majority of revenue is generated from the United States.

Share on Social Networks: